Copyright © 2021 Pharmascimed. All Rights Reserved.
Kadcyla
- Home
- Kadcyla
Roche submits Kadcyla for real-time FDA review
- February 5, 2019
- 0
Roche is aiming to hasten use of its breast cancer drug Kadcyla with the submission to the FDA under the Real-Time Oncology Review and Assessment Aid programme. Kadcyla (trastuzumab emtansine)...
Read moreTrending
Recent Posts
The coming age of biosimilars
- February 26, 2019
- 0
Novartis acquires game-changing cardiovascular therapy
- February 25, 2019
- 0
Roche buys gene therapy company Spark for $4.3bn
- February 25, 2019
- 0
AbbVie and Voyager Therapeutics in Parkinson’s Pact
- February 22, 2019
- 0